The U.S. FDA has approved Palforzia, the oral immunotherapy (OIT) for peanut allergy, for treatment in toddlers with peanut allergy. … Read more »
Tag: Palforzia
Therapy Aims to Turn IgE Allergy Antibodies into Reaction Blockers
A biotech company has developed a technique that transforms the antibodies that trigger allergic reactions into reaction blockers. Their first… Read more »
Could a Special Toothpaste Help Brush Away Peanut Allergies?
Along with clean teeth, a specially formulated toothpaste may help increase tolerance to peanut in those with peanut allergy, a… Read more »
Viaskin Peanut Patch Desensitized Most Toddlers in Phase 3 Trial
The Viaskin patch for peanut allergy is showing promise in desensitizing peanut-allergic toddlers in a late-stage trial. After wearing the… Read more »
‘Very Low-Dose’ Peanut Oral Immunotherapy Helps Desensitize
Oral immunotherapy using even very small amounts of peanut helps with desensitization and protecting from reactions due to accidental ingestion,… Read more »
Will an OIT Formula for Multiple Food Allergies Come Soon?
As a baby, Daniel Lubetzky’s son had an allergic reaction to pineapple, and later, birthday cake. “We eventually connected the… Read more »
AAAAI News: Dupilumab Remission; Tezepelumab in Severe Asthma; Palforzia Safety
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
FARE Retreat: Experts Explore Food Allergy Treatment, Testing
“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
Europe’s Palforizia OIT Study Shows Speed of Desensitization
Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Learning More About Oral Immunotherapy for Food Allergy
Allergist Dr. Michael Manning explains how oral immunotherapy (OIT) for food allergy works and shares his experience working with families to ease anxiety.